Mycoplasma Detection Test
Detection of Mycoplasma contamination in cell cultures (Biotechnology/R&D Laboratories)
Key Facts
About certus molecular diagnostics
Certus Molecular Diagnostics AG is a privately held Swiss company established in 2017 by a physician and a biologist to solve critical diagnostic challenges in biotechnology and research laboratories. The company's core mission is to set new standards in diagnostics by combining clinical and diagnostic expertise to create rapid, simple, and reliable molecular tests. It has won several entrepreneurial awards and launched multiple products internationally, supported by a consortium of Swiss innovation grants and foundations. Certus is positioned to capture market share by replacing time-consuming, laborious, and unreliable current procedures for pathogen detection.
View full company profile